hCD24

Nomenclature

C57BL/6Smoc-Cd24atm1(hCD24)Smoc

Cat. NO.

NM-HU-2000060

Strain State

Embryo cryopreservation

Export PDF

Gene Summary

Gene Symbol
CD24a

Synonyms

HSA; Cd24; Ly-52; nectadrin

NCBI ID

12484

MGI ID

88323

Ensembl ID

ENSMUSG00000047139

Pubmed

CD24a

Human Ortholog

CD24A

Model Description

The endogenous mouse Cd24a gene was replaced by human CD24 gene. While hCD24(2)(Stock No.NM-HU-215025) mice function similarly to hCD24 mice, for more detailed information please contact our technical advisor.
Research Application：Immunotherapy,drug screening

Validation Data

image.png

Fig1. Detection of CD24 expression in spleen and brain by RT-PCR. Wild type: only one band at 175 bp with primers F1/R1(mCd24);Homozygous: only one band at 202 bp with primers F2/R2(hCD24); Abbr.. M, DNA marker; HO, homozygous; HE, heterozygous; WT, wild type.

image.png

Fig2. Detection of hCD24 expression on B cells and T cells in blood in hCD24 KI mice.

image.png

Fig3. Detection of hCD24 expression on macrophages, neutrophils and DCs in blood in hCD24 KI mice.

image.png

Fig4. Detection of hCD24 expression on B cells and T cells in spleen in hCD24 KI mice.

image.png

Fig5. Detection of hCD24 expression on macrophages, neutrophils and DCs in spleen in hCD24 KI mice.

image.png

Fig6. Detection of hCD24 expression on RBC (red blood cells)  in hCD24 KI mice.

You may also like

Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute

On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.

Learn more
Workshop：Progress and Advances in Preclinical immuno-Oncology Research

SMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.

Learn more